Examining the autoimmune disease at the molecular level led researchers to a specific molecule that could be contributing to the disease progression in patients.
A new and novel outcome measure is being used to determine effectiveness of new scleroderma treatments. Learn how Michigan Medicine is leading the way.
U-M researchers are studying an overabundant signaling protein tied to UV light sensitivity in patients with lupus.
A new study from researchers at Michigan Medicine explores links between chronic joint inflammation and cognitive impairment.
New research documents how chemicals and a certain gene activate an enzyme to increase the risk and severity of RA and bone destruction.